Mannkind Drug Patent Portfolio
Mannkind owns 1 orange book drug protected by 48 US patents Given below is the list of Mannkind's drug patents along with their expiration dates.
Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
---|---|---|---|
US8636001 | Dry powder inhaler and system for drug delivery | 12 Jul, 2032 | Active |
US8499757 | Dry powder inhaler and system for drug delivery | 19 Feb, 2032 | Active |
US8424518 | Dry powder inhaler and system for drug delivery | 17 Oct, 2031 | Active |
US9597374 | Use of ultrarapid acting insulin | 08 Oct, 2031 | Active |
US8227409 | Diketopiperazine microparticles with defined isomer contents | 08 Mar, 2031 | Active |
US9358352 | Dry powder drug delivery system and methods | 15 Feb, 2031 | Active |
US10500159 | Apparatus and method for cryogranulating a pharmaceutical composition | 02 Nov, 2030 | Active |
US10201672 | Dry powder inhaler and system for drug delivery | 02 Aug, 2030 | Active |
US8551528 | Diketopiperazine microparticles with defined specific surface areas | 11 Jun, 2030 | Active |
US8734845 | Diketopiperazine microparticles with defined specific surface areas | 11 Jun, 2030 | Active |
US8778403 | Diketopiperazine microparticles with defined specific surface areas | 11 Jun, 2030 | Active |
US8485180 | Dry powder drug delivery system | 25 Mar, 2030 | Active |
US9511198 | Dry powder inhaler and system for drug delivery | 16 Feb, 2030 | Active |
US9339615 | Dry powder inhaler and system for drug delivery | 20 Oct, 2029 | Active |
US8623817 | Method of treating diabetes type 2 by administering ultrarapid acting insulin | 18 Sep, 2029 | Active |
US10046031 | Use of ultrarapid acting insulin | 11 Aug, 2029 | Active |
US8119593 | Method of treating diabetes type 2 by metformin and an ultrarapid acting insulin | 11 Aug, 2029 | Active |
US8258095 | Method of controlling glycemia by ultrarapid acting insulin without adjusting an insulin dose for meal content | 11 Aug, 2029 | Active |
US9943571 | Use of ultrarapid acting insulin | 11 Aug, 2029 | Active |
US9393372 | Dry powder drug delivery system | 04 Jul, 2029 | Active |
US10342938 | Dry powder drug delivery system | 12 Jun, 2029 | Active |
US8912193 | Dry powder inhaler and system for drug delivery | 12 Jun, 2029 | Active |
US9192675 | Dry powder inhaler and system for drug delivery | 12 Jun, 2029 | Active |
US9446133 | Dry powder inhaler and system for drug delivery | 12 Jun, 2029 | Active |
US9662461 | Dry powder drug delivery system and methods | 12 Jun, 2029 | Active |
US8729019 | Method of drug formulation based on increasing the affinity of crystalline microparticle surfaces for active agents | 26 Dec, 2028 | Active |
US9283193 | Method of drug formulation based on increasing the affinity of crystalline microparticle surfaces for active agents | 14 Sep, 2026 | Active |
US9717689 | Method of drug formulation based on increasing the affinity of crystalline microparticle surfaces for active agents | 14 Sep, 2026 | Active |
US7943572 | Superior control of blood glucose in diabetes treatment | 10 Aug, 2026 | Active |
US8146588 | Unit dose capsules and dry powder inhaler | 24 Apr, 2023 | Expired |
US7464706 | Unit dose cartridge and dry powder inhaler | 02 Mar, 2023 | Expired |
US7305986 | Unit dose capsules for use in a dry powder inhaler | 16 Jan, 2023 | Expired |
US8156936 | Unit dose capsules and dry powder inhaler | 16 Jan, 2023 | Expired |
US8215300 | Unit dose cartridge and dry powder inhaler | 24 Nov, 2022 | Expired |
US8950397 | Unit dose cartridge and dry powder inhaler | 20 Jul, 2021 | Expired |
US6444226 | Purification and stabilization of peptide and protein pharmaceutical agents | 29 Jun, 2020 | Expired |
US6652885 | Purification and stabilization of peptide and protein pharmaceutical agents | 29 Jun, 2020 | Expired |
US7648960 | Method for delivery of monomeric or dimeric insulin complexed to diketopiperazine microparticles | 29 Jun, 2020 | Expired |
US7943178 | Methods and compositions for delivering peptides | 29 Jun, 2020 | Expired |
US8389470 | Methods and compositions for delivering peptides | 29 Jun, 2020 | Expired |
US8889099 | Methods and compositions for delivering peptides | 29 Jun, 2020 | Expired |
US6071497 | Microparticles for lung delivery comprising diketopiperazine | 15 May, 2015 | Expired |
US6428771 | Method for drug delivery to the pulmonary system | 15 May, 2015 | Expired |
US8394414 | Method for drug delivery to the pulmonary system | 15 May, 2015 | Expired |
US6663898 | Carbon-substituted diketopiperazine delivery systems | 30 Sep, 2014 | Expired |
US6906030 | Carbon-substituted diketopiperazine delivery systems | 30 Sep, 2014 | Expired |
US7276534 | Carbon-substituted diketopiperazine delivery systems | 30 Sep, 2014 | Expired |
US8133514 | Carbon-substituted diketopiperazine delivery systems | 30 Sep, 2014 | Expired |
Latest Legal Activities on Mannkind's Drug Patents
Given below is the list of recent legal activities going on the following drug patents of Mannkind.
Activity | Date | Patent Number |
---|---|---|
Payment of Maintenance Fee, 8th Year, Large Entity | 06 Jun, 2024 | US9511198 |
Expire Patent
Critical
| 20 May, 2024 | US8156936 |
Expire Patent
Critical
| 06 May, 2024 | US8146588 |
Payment of Maintenance Fee, 8th Year, Large Entity | 20 Mar, 2024 | US9446133 |
Payment of Maintenance Fee, 12th Yr, Small Entity | 04 Mar, 2024 | US8258095 |
Maintenance Fee Reminder Mailed
Critical
| 26 Feb, 2024 | US8215300 |
Payment of Maintenance Fee, 12th Year, Large Entity | 24 Jan, 2024 | US8227409 |
Payment of Maintenance Fee, 8th Year, Large Entity | 19 Jan, 2024 | US9393372 |
Payment of Maintenance Fee, 8th Year, Large Entity | 07 Dec, 2023 | US9358352 |
Maintenance Fee Reminder Mailed
Critical
| 04 Dec, 2023 | US8156936 |
Maintenance Fee Reminder Mailed
Critical
| 20 Nov, 2023 | US8146588 |
Payment of Maintenance Fee, 8th Year, Large Entity | 17 Nov, 2023 | US9339615 |
Payment of Maintenance Fee, 8th Year, Large Entity | 15 Sep, 2023 | US9283193 |
Payment of Maintenance Fee, 12th Yr, Small Entity | 21 Aug, 2023 | US8119593 |
Expire Patent
Critical
| 19 Jun, 2023 | US7943178 |
Mannkind's Drug Patent Litigations
Mannkind's drugs have been subject to various legal proceedings, including patent litigations. The earliest legal proceeding was initiated on Nov 17, 1997, against patent number US6428771. The petitioner , challenged the validity of this patent, with STEINER et al as the respondent. Click below to track the latest information on how companies are challenging Mannkind's patents.
Patent | Proceeding Filing Date | Status | Respondent | Petitioner |
---|---|---|---|---|
US9597374 | June, 2014 |
Decision
(17 Aug, 2016)
| Anders Hasager Boss et al | |
US7305986 | December, 2006 |
Decision
(30 Apr, 2007)
| Solomon S. Steiner et al | |
US6428771 | November, 1997 |
Decision
(29 May, 2001)
| STEINER et al |
Mannkind's Family Patents
Mannkind Drug List
Given below is the complete list of Mannkind's drugs and the patents protecting them.
1. Afrezza
Afrezza is protected by 48 patents, out of which 19 have expired. Check out its patent list below.
Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
---|---|---|---|
US8636001 | Dry powder inhaler and system for drug delivery |
12 Jul, 2032
(7 years from now)
| Active |
US8499757 | Dry powder inhaler and system for drug delivery |
19 Feb, 2032
(7 years from now)
| Active |
US8424518 | Dry powder inhaler and system for drug delivery |
17 Oct, 2031
(6 years from now)
| Active |
US9597374 | Use of ultrarapid acting insulin |
08 Oct, 2031
(6 years from now)
| Active |
US8227409 | Diketopiperazine microparticles with defined isomer contents |
08 Mar, 2031
(6 years from now)
| Active |
US9358352 | Dry powder drug delivery system and methods |
15 Feb, 2031
(6 years from now)
| Active |
US10500159 | Apparatus and method for cryogranulating a pharmaceutical composition |
02 Nov, 2030
(5 years from now)
| Active |
US10201672 | Dry powder inhaler and system for drug delivery |
02 Aug, 2030
(5 years from now)
| Active |
US8551528 | Diketopiperazine microparticles with defined specific surface areas |
11 Jun, 2030
(5 years from now)
| Active |
US8734845 | Diketopiperazine microparticles with defined specific surface areas |
11 Jun, 2030
(5 years from now)
| Active |
US8778403 | Diketopiperazine microparticles with defined specific surface areas |
11 Jun, 2030
(5 years from now)
| Active |
US8485180 | Dry powder drug delivery system |
25 Mar, 2030
(5 years from now)
| Active |
US9511198 | Dry powder inhaler and system for drug delivery |
16 Feb, 2030
(5 years from now)
| Active |
US9339615 | Dry powder inhaler and system for drug delivery |
20 Oct, 2029
(4 years from now)
| Active |
US8623817 | Method of treating diabetes type 2 by administering ultrarapid acting insulin |
18 Sep, 2029
(4 years from now)
| Active |
US10046031 | Use of ultrarapid acting insulin |
11 Aug, 2029
(4 years from now)
| Active |
US8119593 | Method of treating diabetes type 2 by metformin and an ultrarapid acting insulin |
11 Aug, 2029
(4 years from now)
| Active |
US8258095 | Method of controlling glycemia by ultrarapid acting insulin without adjusting an insulin dose for meal content |
11 Aug, 2029
(4 years from now)
| Active |
US9943571 | Use of ultrarapid acting insulin |
11 Aug, 2029
(4 years from now)
| Active |
US9393372 | Dry powder drug delivery system |
04 Jul, 2029
(4 years from now)
| Active |
US10342938 | Dry powder drug delivery system |
12 Jun, 2029
(4 years from now)
| Active |
US8912193 | Dry powder inhaler and system for drug delivery |
12 Jun, 2029
(4 years from now)
| Active |
US9192675 | Dry powder inhaler and system for drug delivery |
12 Jun, 2029
(4 years from now)
| Active |
US9446133 | Dry powder inhaler and system for drug delivery |
12 Jun, 2029
(4 years from now)
| Active |
US9662461 | Dry powder drug delivery system and methods |
12 Jun, 2029
(4 years from now)
| Active |
US8729019 | Method of drug formulation based on increasing the affinity of crystalline microparticle surfaces for active agents |
26 Dec, 2028
(4 years from now)
| Active |
US9283193 | Method of drug formulation based on increasing the affinity of crystalline microparticle surfaces for active agents |
14 Sep, 2026
(1 year, 9 months from now)
| Active |
US9717689 | Method of drug formulation based on increasing the affinity of crystalline microparticle surfaces for active agents |
14 Sep, 2026
(1 year, 9 months from now)
| Active |
US7943572 | Superior control of blood glucose in diabetes treatment |
10 Aug, 2026
(1 year, 7 months from now)
| Active |
US8146588 | Unit dose capsules and dry powder inhaler |
24 Apr, 2023
(1 year, 7 months ago)
| Expired |
US7464706 | Unit dose cartridge and dry powder inhaler |
02 Mar, 2023
(1 year, 9 months ago)
| Expired |
US7305986 | Unit dose capsules for use in a dry powder inhaler |
16 Jan, 2023
(1 year, 10 months ago)
| Expired |
US8156936 | Unit dose capsules and dry powder inhaler |
16 Jan, 2023
(1 year, 10 months ago)
| Expired |
US8215300 | Unit dose cartridge and dry powder inhaler |
24 Nov, 2022
(2 years ago)
| Expired |
US8950397 | Unit dose cartridge and dry powder inhaler |
20 Jul, 2021
(3 years ago)
| Expired |
US6444226 | Purification and stabilization of peptide and protein pharmaceutical agents |
29 Jun, 2020
(4 years ago)
| Expired |
US6652885 | Purification and stabilization of peptide and protein pharmaceutical agents |
29 Jun, 2020
(4 years ago)
| Expired |
US7648960 | Method for delivery of monomeric or dimeric insulin complexed to diketopiperazine microparticles |
29 Jun, 2020
(4 years ago)
| Expired |
US7943178 | Methods and compositions for delivering peptides |
29 Jun, 2020
(4 years ago)
| Expired |
US8389470 | Methods and compositions for delivering peptides |
29 Jun, 2020
(4 years ago)
| Expired |
US8889099 | Methods and compositions for delivering peptides |
29 Jun, 2020
(4 years ago)
| Expired |
US6071497 | Microparticles for lung delivery comprising diketopiperazine |
15 May, 2015
(9 years ago)
| Expired |
US6428771 | Method for drug delivery to the pulmonary system |
15 May, 2015
(9 years ago)
| Expired |
US8394414 | Method for drug delivery to the pulmonary system |
15 May, 2015
(9 years ago)
| Expired |
US6663898 | Carbon-substituted diketopiperazine delivery systems |
30 Sep, 2014
(10 years ago)
| Expired |
US6906030 | Carbon-substituted diketopiperazine delivery systems |
30 Sep, 2014
(10 years ago)
| Expired |
US7276534 | Carbon-substituted diketopiperazine delivery systems |
30 Sep, 2014
(10 years ago)
| Expired |
US8133514 | Carbon-substituted diketopiperazine delivery systems |
30 Sep, 2014
(10 years ago)
| Expired |
Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Afrezza's drug page